Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlfa Financial Software Holdings Regulatory News (ALFA)

Share Price Information for Alfa Financial Software Holdings (ALFA)

Share Price is delayed by 15 minutes
Get Live Data
155.80    3.20 (2.10%)
Bid:
152.80
Ask:
155.20
Spread: 2.40 (1.571%)
Market Cap: £463.14m
ALFA Live PriceLast checked at - London Stock Exchange

Intraday Alfa Financial Software Holdings Share Chart

Post-Stabilisation Period Announcement

5 Jun 2017 16:57

RNS Number : 1909H
Barclays Capital Securities Limited
05 June 2017
 

5 June 2017

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Alfa Financial Software Holdings PLC

Post-Stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 26 May 2017 Barclays Bank PLC ('Barclays') (Ben West; telephone: +44 20 7773 9531) hereby gives notice that as Stabilising Coordinator, the Stabilisation Manager named below undertook stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) and of the rules of the Financial Conduct Authority) in relation to the offer of the following securities, as set out below.

 

The securities:

Issuer:

Alfa Financial Software Holdings PLC

Aggregate nominal amount/Offering size:

78,000,000 Ordinary Shares (excluding the over-allotment option)

Description:

Ordinary Shares in Alfa Financial Software Holdings PLC with a nominal value of 0.1 pence per Share. ISIN: GB00BDHXPG30

Offer price:

 325p

Stabilisation:

Stabilisation Manager:

Barclays Capital Securities Limited, 5 The North Colonnade, Canary Wharf, London, E14 4BB, United Kingdom

Stabilisation started on:

 26th May 2017

Stabilisation last occurred on:

5th June 2017

 

Although stabilisation offers were made, no stabilisation transactions were carried out.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the 'Securities Act'), or under the securities laws of any state or other jurisdiction of the United States. Accordingly, the securities referred to herein may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in or into, the United States absent registration under, or pursuant to an exemption from, the registration requirements of the Securities Act and in compliance with any relevant state securities laws. There will be no public offer of securities in the United States.

Barclays is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority, is acting for the Issuer only in connection with the offer and will not be responsible to anyone other than the Issuer for providing the protections offered to clients of Barclays, nor for providing advice in relation to the offer or any matters referred to in this communication.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAUGUAAQUPMGAA
Date   Source Headline
11th May 20264:48 pmRNSHolding(s) in Company
30th Apr 20265:17 pmRNSTotal Voting Rights
30th Apr 20263:48 pmRNSResult of the 2026 AGM
30th Apr 20267:00 amRNSQ1 26 Trading update
13th Apr 20264:02 pmRNSAwards under the LTIP and DBSP
9th Apr 202610:34 amRNSVesting of award under the LTIP
31st Mar 20269:36 amRNSAnnual Report and Accounts and Notice of 2026 AGM
12th Mar 20267:00 amRNSFull Year Results for year ended 31 December 2025
2nd Mar 20266:09 pmRNS-RFY25 analyst and retail investor presentations
12th Feb 20267:00 amRNSAppointment of Chief Financial Officer
30th Jan 20264:52 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSQ4 25 Trading update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSRetirement of Director
23rd Dec 20257:00 amRNSRetirement of Director
12th Dec 20252:42 pmRNSHolding(s) in Company
12th Dec 20257:00 amRNSAppointment of Independent Non-Executive Director
1st Dec 202510:29 amRNSTotal Voting Rights
13th Nov 20257:00 amRNSQ3 2025 Trading update
30th Sep 20255:48 pmRNSTotal Voting Rights
4th Sep 20257:00 amRNS2025 Half Year Report
21st Aug 20252:52 pmRNS-RNotice of H1 results and presentations
31st Jul 20255:06 pmRNSTotal Voting Rights
30th Jul 20257:00 amRNSH1 Trading update
30th Jun 20254:48 pmRNSTotal Voting Rights
30th May 20255:38 pmRNSTotal Voting Rights
8th May 20259:51 amRNSGrant of options under the Sharesave Plan
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20254:03 pmRNSResult of the 2025 AGM
29th Apr 20257:00 amRNSQ1 Trading update
15th Apr 202512:59 pmRNSAward under the LTIP and DBSP
15th Apr 202512:46 pmRNSVesting of awards under the LTIP
1st Apr 20257:00 amRNSNotice of 2025 AGM and Annual Report and Accounts
31st Mar 20254:40 pmRNSTotal Voting Rights
13th Mar 20257:00 amRNSFull Year Results for year ended 31 December 2024
3rd Mar 20252:49 pmRNSInvestor Presentation via Investor Meet Company
28th Feb 20255:10 pmRNSTotal Voting Rights
31st Jan 20254:51 pmRNSTotal Voting Rights
30th Jan 20257:00 amRNSQ4 Trading update
17th Jan 20257:00 amRNS-RAlfa Systems’ Software Evolution IR Video
3rd Jan 20251:37 pmRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSQ3 Trading update
28th Oct 20241:52 pmRNSDirector/PDMR Shareholding
13th Sep 202412:03 pmRNSPerson Closely Associated Notification
10th Sep 20249:30 amRNSHolding(s) in Company
9th Sep 202410:31 amRNSHolding(s) in Company
5th Sep 20247:01 amRNSAppointment of Additional Corporate Broker
5th Sep 20247:00 amRNS2024 Half Year Report
7th Aug 20249:05 amRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.